Keywords: AEterna Zentaris, Perifosine, Potential in mesothelioma, MMe

AEterna Zentaris' perifosine seen as potential novel approach for mesothelioma

Article | 31 May 2012

Canada-based AEterna Zentaris (TSX: AEZ) has highlighted an article published in the May 2012 issue of Plos One, which outlines a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in